Lopez-Garcia M A, Geyer F C, Lacroix-Triki M, et al. Breast cancer precursors revisited: molecular features and progression pathways[J]. Histopathology, 2010, 57(2): 171-192. [2]Moasser M M. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis[J]. Oncogene, 2007, 26(45): 6469-6487. [3]Curtis C, Shah S P, Chin S F, et al. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups[J]. Nature, 2012, 486(7403): 346-352. [4]Mukai H. Treatment strategy for HER2-positive breast cancer[J]. Int J Clin Oncol, 2010, 15(4): 335-340. [5]Bender L M, Nahta R. Her2 cross talk and therapeutic resistance in breast cancer[J]. Front Biosci, 2008, 13: 3906-3912. [6]Leary A F, Hanna W M, van-de-Vijver M J, et al. Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients[J]. J Clin Oncol, 2009, 27(10): 1694-1705. [7]Sasso M, Bianchi F, Ciravolo V, et al. HER2 splice variants and their relevance in breast cancer[J]. J Nucleic Acids Investig, 2011, 2(1): 52-59. [8]Mitra D, Brumlik M J, Okamgba S U, et al. An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance[J]. Mol Cancer Ther, 2009, 8(8): 2152-2162. [9]Kang L, Wang L, Wang Z Y. Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms’ tumor suppressor WT1[J]. Oncol Lett, 2011, 2(2): 337-341. [10]姜晓梅, 陈彬, 韩谊, 等.非基因组活性对雌激素受体阳性乳腺癌细胞Herceptin敏感性的影响[J]. 第三军医大学学报, 2011, 33(9): 908-911. [11]Lin S L, Yan L Y, Zhang X T, et al. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells ？via？ the MAPK/ERK and PI3K/Akt pathways[J]. PLoS One, 2010, 5(2): e9013. [12]Rao J, Jiang X, Wang Y, et al. Advances in the understanding of the structure and function of ER-α36, a novel variant of human estrogen receptor-alpha[J]. J Steroid Biochem Mol Biol, 2011, 127(3/5): 231-237. [13]Deng H, Huang X, Fan J, et al. A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis[J]. Oncol Rep, 2010, 24(1): 171-176. [14]Fu Z, Deng H, Wang X, et al. Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression[J]. Histopathology, 2013, 63(3): 325-333. [15]Wang Z, Zhang X, Shen P, et al. A variant of estrogen receptor{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling[J]. Proc Natl Acad Sci U S A, 2006, 103(24): 9063-9068. [16]Vranic S, Gatalica Z, Deng H, et al. ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast[J]. J Clin Pathol, 2011, 64(1): 54-57. [17]Pelekanou V, Notas G, Kampa M, et al. ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines[J]. Steroids, 2012, 77(10): 928-934. [18]Su X, Xu X, Li G, et al. ER-α36: a novel biomarker and potential therapeutic target in breast cancer[J]. Onco Targets Ther, 2014, 7: 1525-1533.
[2]
朱宁生,张婧,曾晓华,等.BMP-4基因影响乳腺癌细胞增殖、凋亡和迁移能力涉及NF-κB途径[J].第三军医大学学报,2012,34(18):1910. [2]陈显春,杨英,宋爽,等.乳腺癌患者发生化疗性静脉炎的原因分析及防治对策[J].第三军医大学学报,2007,29(21):2055. [3]张毅,周艳,郭美琴,等.全乳大切片观察新辅助化疗后乳腺癌浸润性生长特征变化[J].第三军医大学学报,2007,29(21):2083. ZHANG Yi,ZHOU Yan,GUO Mei-qin,et al.Infiltrating characteristics of breast cancer after neoadjuvant chemotherapy: whole breast serial subsection observation[J].J Third Mil Med Univ,2007,29(11):2083. [4]陈显春,杨英,宋爽,等.乳腺癌病友联谊会对提高乳腺癌患者生活质量的作用[J].第三军医大学学报,2007,29(20):1967. [5]邓莉,张轩珍,王卫东,等.重组人内皮抑素联合紫杉醇+顺铂化疗方案治疗人乳腺癌？鼠移植瘤的研究[J].第三军医大学学报,2008,30(09):783. DENG Li,ZHANG Xuan-zhen,WANG Wei-dong,et al.Recombinant human endostatin combined with paclitaxel-cisplatin chemotherapy in treatment of human breast cancer xenograft in nude mice[J].J Third Mil Med Univ,2008,30(11):783. [6]黄红梅,陈显春.男性乳腺癌患者的心理分析及对策[J].第三军医大学学报,2007,29(23):2222. [7]杨新华,姜军,范林军,等.乳腺癌腔镜内乳淋巴结清扫的初步研究[J].第三军医大学学报,2007,29(17):1719. YANG Xin-hua,JIANG Jun,FAN Lin-jun,et al.Thoracoscopic internal mammary nodes dissection for breast cancer[J].J Third Mil Med Univ,2007,29(11):1719. [8]廖翠薇,邹利光,戴书华,等.动态增强磁共振成像对乳腺癌的诊断[J].第三军医大学学报,2008,30(16):1516. LIAO Cui-wei,ZOU Li-guang,DAI Shu-hua,et al.Diagnosis of breast cancer with dynamic contrast-enhanced magnetic resonance imaging[J].J Third Mil Med Univ,2008,30(11):1516. [9]张涛,汤为学,蔡辉,等.不同转移潜能乳腺癌细胞亚系的建立与生物学特性的分析[J].第三军医大学学报,2008,30(18):1726. ZHANG Tao,TANG Wei-xue,CAI Hui,et al.Establishment of breast cancer cell sublines with different potential of metastasis and their biological characteristics[J].J Third Mil Med Univ,2008,30(11):1726. [10]李霞,邓华瑜.格尔德霉素对乳腺癌细胞HSP、突变型p53和CDK4表达的影响[J].第三军医大学学报,2007,29(13):1320. LI Xia,DENG Hua-yu.Effects of geldanamycin on expression of HSP, mutant p53 and CDK4 in human breast cancer cells[J].J Third Mil Med Univ,2007,29(11):1320.
